The field of mechanical circulatory support (MCS) has evolved from earlier-generation pulsatile-flow devices that were primarily used to support critically ill patients in the hospital to newer-generation continuous-flow devices that permit hospital discharge and resumption of normal life activities. The technology is used to bridge transplant-eligible patients and can be used for long-term support of patients who are transplant ineligible. Left ventricular assist devices are proved to improve long-term survival and quality of life for patients with advanced heart failure. Adverse events associated with MCS therapy remain the Achilles heel of the field and strategies to improve biocompatibility are ongoing
The impact of left ventricular assist devices (LVADs) for the treatment of advanced heart failure ha...
ObjectivesThis study sought to evaluate the use of a continuous-flow rotary left ventricular assist ...
Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart ...
For more than 30 years, heart transplantation has been a successful therapy for patients with termin...
Cardiogenic shock due to acute myocardial infarction, postcardiotomy syndrome following cardiac surg...
Severe heart failure has a poor prognosis. Mechanical circulatory support (MCS) is capable of assist...
Heart failure is a major public health problem and its management requires a significant amount of h...
ObjectivesAverage 2-year survival after cardiac transplantation is approximately 80%. The evolution ...
The era of mechanical circulatory support (MCS) began in1953 with the development of cardiopulmonary...
With the advent of new technologies, experience with long-term mechanical circulatory support (MCS) ...
Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart ...
Heart transplantation (HTx) is the treatment of choice for end-stage heart failure but the limited a...
Mortality from cardiogenic shock primarily in the setting of acute myocardial infarction is unchange...
Mortality from cardiogenic shock primarily in the setting of acute myocardial infarction is unchange...
Heart transplantation (HTx) is the treatment of choice for end-stage heart failure but the limited a...
The impact of left ventricular assist devices (LVADs) for the treatment of advanced heart failure ha...
ObjectivesThis study sought to evaluate the use of a continuous-flow rotary left ventricular assist ...
Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart ...
For more than 30 years, heart transplantation has been a successful therapy for patients with termin...
Cardiogenic shock due to acute myocardial infarction, postcardiotomy syndrome following cardiac surg...
Severe heart failure has a poor prognosis. Mechanical circulatory support (MCS) is capable of assist...
Heart failure is a major public health problem and its management requires a significant amount of h...
ObjectivesAverage 2-year survival after cardiac transplantation is approximately 80%. The evolution ...
The era of mechanical circulatory support (MCS) began in1953 with the development of cardiopulmonary...
With the advent of new technologies, experience with long-term mechanical circulatory support (MCS) ...
Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart ...
Heart transplantation (HTx) is the treatment of choice for end-stage heart failure but the limited a...
Mortality from cardiogenic shock primarily in the setting of acute myocardial infarction is unchange...
Mortality from cardiogenic shock primarily in the setting of acute myocardial infarction is unchange...
Heart transplantation (HTx) is the treatment of choice for end-stage heart failure but the limited a...
The impact of left ventricular assist devices (LVADs) for the treatment of advanced heart failure ha...
ObjectivesThis study sought to evaluate the use of a continuous-flow rotary left ventricular assist ...
Mechanical circulatory support (MCS) methods are used in patients with both acute and chronic heart ...